rs17272089

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_152383.5(DIS3L2):​c.1170C>T​(p.Leu390Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.025 in 1,613,548 control chromosomes in the GnomAD database, including 638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 39 hom., cov: 32)
Exomes 𝑓: 0.026 ( 599 hom. )

Consequence

DIS3L2
NM_152383.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.681

Publications

7 publications found
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]
DIS3L2 Gene-Disease associations (from GenCC):
  • Perlman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 2-232210371-C-T is Benign according to our data. Variant chr2-232210371-C-T is described in ClinVar as Benign. ClinVar VariationId is 334936.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.681 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0176 (2688/152304) while in subpopulation SAS AF = 0.0447 (215/4810). AF 95% confidence interval is 0.0398. There are 39 homozygotes in GnomAd4. There are 1252 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIS3L2NM_152383.5 linkc.1170C>T p.Leu390Leu synonymous_variant Exon 10 of 21 ENST00000325385.12 NP_689596.4
DIS3L2NM_001257281.2 linkc.1170C>T p.Leu390Leu synonymous_variant Exon 10 of 14 NP_001244210.1
DIS3L2NR_046476.2 linkn.1316C>T non_coding_transcript_exon_variant Exon 10 of 21
DIS3L2NR_046477.2 linkn.1292C>T non_coding_transcript_exon_variant Exon 9 of 19

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkc.1170C>T p.Leu390Leu synonymous_variant Exon 10 of 21 5 NM_152383.5 ENSP00000315569.7

Frequencies

GnomAD3 genomes
AF:
0.0177
AC:
2687
AN:
152186
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00475
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0130
Gnomad ASJ
AF:
0.0308
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0440
Gnomad FIN
AF:
0.00886
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0264
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.0215
AC:
5373
AN:
249530
AF XY:
0.0234
show subpopulations
Gnomad AFR exome
AF:
0.00452
Gnomad AMR exome
AF:
0.0141
Gnomad ASJ exome
AF:
0.0290
Gnomad EAS exome
AF:
0.000222
Gnomad FIN exome
AF:
0.00988
Gnomad NFE exome
AF:
0.0257
Gnomad OTH exome
AF:
0.0243
GnomAD4 exome
AF:
0.0258
AC:
37725
AN:
1461244
Hom.:
599
Cov.:
31
AF XY:
0.0264
AC XY:
19169
AN XY:
726942
show subpopulations
African (AFR)
AF:
0.00442
AC:
148
AN:
33470
American (AMR)
AF:
0.0143
AC:
640
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0284
AC:
743
AN:
26116
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39682
South Asian (SAS)
AF:
0.0401
AC:
3459
AN:
86246
European-Finnish (FIN)
AF:
0.00914
AC:
488
AN:
53376
Middle Eastern (MID)
AF:
0.0372
AC:
214
AN:
5760
European-Non Finnish (NFE)
AF:
0.0274
AC:
30508
AN:
1111520
Other (OTH)
AF:
0.0252
AC:
1521
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
1857
3713
5570
7426
9283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1168
2336
3504
4672
5840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0176
AC:
2688
AN:
152304
Hom.:
39
Cov.:
32
AF XY:
0.0168
AC XY:
1252
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00474
AC:
197
AN:
41576
American (AMR)
AF:
0.0131
AC:
200
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0308
AC:
107
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5182
South Asian (SAS)
AF:
0.0447
AC:
215
AN:
4810
European-Finnish (FIN)
AF:
0.00886
AC:
94
AN:
10612
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0264
AC:
1794
AN:
68032
Other (OTH)
AF:
0.0222
AC:
47
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
133
266
400
533
666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0232
Hom.:
24
Bravo
AF:
0.0169
Asia WGS
AF:
0.0130
AC:
45
AN:
3478
EpiCase
AF:
0.0286
EpiControl
AF:
0.0270

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Perlman syndrome Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Mar 22, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
5.1
DANN
Benign
0.80
PhyloP100
-0.68
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17272089; hg19: chr2-233075081; COSMIC: COSV56047717; API